Wellington Management Group
ACRS icon

Wellington Management Group’s Aclaris Therapeutics ACRS Stock Holding History

Wellington Management Group’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Buy
267,498
+10,342
+4% +$46.1K ﹤0.01% 1691
2026
Q1 		$964K Sell
257,156
-7,203
-3% -$24.3K ﹤0.01% 1683
2025
Q4 		$796K Buy
+264,359
New +$668K ﹤0.01% 1757
2023
Q4 		– Sell
-6,979,844
Closed -$47.8M – 1816
2023
Q3 		$47.8M Sell
6,979,844
-658,024
-9% -$5.62M 0.01% 703
2023
Q2 		$79.2M Buy
7,637,868
+265,267
+4% +$2.4M 0.02% 601
2023
Q1 		$59.6M Buy
7,372,601
+1,888,588
+34% +$24M 0.01% 650
2022
Q4 		$86.4M Buy
5,484,013
+2,030,160
+59% +$32.7M 0.02% 557
2022
Q3 		$54.4M Sell
3,453,853
-1,447,410
-30% -$22.8M 0.01% 651
2022
Q2 		$68.4M Sell
4,901,263
-828,990
-14% -$11.6M 0.01% 611
2022
Q1 		$98.8M Buy
5,730,253
+190,985
+3% +$2.61M 0.02% 584
2021
Q4 		$80.5M Buy
5,539,268
+118,815
+2% +$1.8M 0.01% 688
2021
Q3 		$97.6M Buy
5,420,453
+722,704
+15% +$11.6M 0.02% 633
2021
Q2 		$82.5M Buy
4,697,749
+3,866,420
+465% +$87.8M 0.01% 686
2021
Q1 		$20.9M Buy
+831,329
New +$16.3M ﹤0.01% 1060
2018
Q2 		– Sell
-32,894
Closed -$577K – 2218
2018
Q1 		$577K Buy
+32,894
New +$697K ﹤0.01% 1994

Other funds holding ACRS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Wellington Management Group's ACRS Position: Q2 2026 in Review

Wellington Management Group increased its Aclaris Therapeutics (ACRS) stake by 4% in Q2 2026, buying an estimated $46.1K and bringing the position to 267,498 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1691.

Wellington Management Group first reported a position in ACRS in Q1 2018 and has held it in 15 quarters since. The position peaked at $98.8M in Q1 2022. 149 funds tracked by Wall St. Rank hold ACRS as of Q2 2026.

  • Wellington Management Group held 267,498 shares of Aclaris Therapeutics worth $1.42M as of Q2 2026.
  • Wellington Management Group bought 10,342 Aclaris Therapeutics shares in Q2 2026, an estimated $46.1K.
  • Aclaris Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1691 holding.
  • Wellington Management Group first reported a position in Aclaris Therapeutics in Q1 2018 and has held it in 15 quarters since.
  • Wellington Management Group's Aclaris Therapeutics position peaked at $98.8M in Q1 2022.
  • 149 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.